Dear Member,
Category H goes live on March 1st, changing reimbursement for key multi-source generics like Omeprazole and Doxazosin.
The immediate risk is stock devaluation. If you hold high volumes of these items during the transition, you will likely face significant margin losses.
To help you prepare quickly, we have condensed the regulations into the attached Category H Strategic Dashboard.
Use this one-page guide to:
- Audit the "First Wave": See the exact 11 items moving to Cat H.
- Protect Cashflow: Reduce stock on these lines by February 28th.
- Update SOPs: Apply new Broken Bulk (BB) and Out of Pocket (XP) rules immediately.
Please download the attachment and display it in your dispensary.
If you have any questions or need support please get in touch with us as usual on
info@pharmaplusltd.co.uk and we will be happy to assist.
Regards,
PharmaPlus